Gianluca Gaidano is a professor of Hematology and Deputy Rector at the University of Eastern Piedmont, Novara, Italy. He started his medical career at the University of Turin, where he received his M.D. and Ph.D. From 1990 to 1994, he was at Columbia University, New York, where he trained in molecular hematology. His research interests relate mainly to precision medicine of lymphoid malignancies, with a focus on non-Hodgkin's lymphoma and CLL molecular predictors and targeted treatments. Other fields of interest concern hematologic neoplasia in immunodeficient patients. He has been a board member of EHA and the Chair of the EHA Global Outreach Program Committee. He has chaired the EHA Community and Stakeholder Committee and served as member in the EHA Education Committee. He is a board member of the Italian Lymphoma Foundation (FIL) and of the GIMEMA Working Party on chronic lymphoproliferative disorders. He has been president of the Italian Society of Experimental Hematology and is a member of EHA, ERIC, ASH, ASCO, AACR, SIE and SIES. He has published over 700 scientific articles (H-index 103; citation index 41562 as of Scopus on Apr 6th, 2025) and contributed to several textbooks. In 2023, he was granted the EHA Education and Mentorship Award at the EHA Congress in Frankfurt.